EyePoint Pharmaceuticals, Inc. Underwriting Agreements
6 Contracts & Agreements
- Underwriting Agreement, dated November 16, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on November 19, 2021)
- Underwriting Agreement, dated February 1, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on February 3, 2021)
- Underwriting Agreement, dated February 21, 2020, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on February 24, 2020)
- Underwriting Agreement, dated March 28, 2019, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on April 1, 2019)
- PSIVIDA CORP. 4,000,000Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 8, 2016)
- PSIVIDA CORP. 3,494,550 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 19, 2013)
